Steven Smith has over three decades of experience in pharmacokinetics, beginning a self-employed consulting career in April 2011. In this role, Steven has provided expertise to 201 pharmaceutical, biotechnology, private equity, and strategy consulting firms across various countries, including the United States, Canada, the United Kingdom, Germany, Switzerland, Israel, China, Singapore, Japan, and Australia. Prior to self-employment, Steven held positions related to drug metabolism and pharmacokinetics at UCB, Adolor, Roche Palo Alto, and Syntex from 1980 to 2011.